ABSTRACT Objective Foetal growth restriction (FGR) affects 10% of pregnancies, contributing to 30% of stillbirths. Current management of early‐onset FGR (< 32 + 0 weeks' gestation) delivers the foetus before stillbirth or irreversible organ damage. The resulting preterm births create additional risks independent of FGR.
George Bray+20 more
wiley +1 more source
Barriers to the implementation of the Newborn Individualized Developmental Care and Assessment Program in neonatal intensive care units and the proposed solutions to improve its implementation: a scoping review. [PDF]
Avazeh M+4 more
europepmc +1 more source
ABSTRACT Objective We aimed to compare health outcomes and costs in standard public maternity care compared to private obstetric‐led maternity care. Design Observational study with linked administrative data. Setting Australian maternity care. Population 867 334 births, covering all births in three states of Australia between 2016 and 2019.
Emily J. Callander+6 more
wiley +1 more source
Improving cognitive development of low‐birth‐weight premature infants with the COPE program: A pilot study of the benefit of early NICU intervention with mothers [PDF]
Bernadette Mazurek Melnyk+11 more
openalex +1 more source
Racial/Ethnic Disparity in NICU Quality of Care Delivery
J. Profit+6 more
semanticscholar +1 more source
Association between labor duration in transvaginal deliveries and the risk of neonatal intensive care unit admission for newborns. [PDF]
Chen H, Zhou C, Yan X, Shao H.
europepmc +1 more source
ABSTRACT Objective To examine associations between a 5‐min Apgar score < 7 and severe neonatal outcomes in very preterm (VPT) infants and how results are impacted by variations in assigning Apgar scores within an international context. Design Prospective observational population‐based cohort study.
Harald Ehrhardt+79 more
wiley +1 more source
Resilience in the shadows of loss: a hermeneutic phenomenological study of neonatal intensive care nurses' coping after infant loss in Saudi Arabia. [PDF]
Elsharkawy NB+11 more
europepmc +1 more source
Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy
Abstract Background and Objectives Untreated opioid use disorder (OUD) in pregnancy is associated with adverse obstetrical outcomes, maternal morbidity, and maternal mortality. This article will inform clinicians about the use of monthly extended‐release buprenorphine (BUP‐XR, SUBLOCADE®) to treat OUD during pregnancy and postpartum.
Melinda Ramage+3 more
wiley +1 more source